From protocol design to submission of study documents, Arkans is a source of top scientific, medical, regulatory, and operational expertise. The quality of our full-service portfolio is built on the expertise of our team: scientific advisors, regulatory strategists, and research professionals, all focused on your project’s success.
Preloader Close
A
R
K
A
N
S
-CRO
Arkans - Clinical Research Organization
Contact Info
-
Call Us
-
Call Us
-
E-mail Us
Rare Diseases & Orphan Drugs
Experience professionals you can trust
Rare Diseases and Orphan Drugs has worked with a wide variety of compounds, including small molecules and biologics, across all phases of clinical development and real-world evidence studies.
We understand the unique challenges these studies pose and have specific strategies to mitigate risks. These strategies include:
From a single service to full program management
- Country-specific regulatory strategies
- Recruitment strategies geared toward rare patient populations
- Investigator site training and specialized communications
Last 5 years rare disease experience, 50+ studies in multiple indications
- Giant Cell Arteritis
- Tuberous Sclerosis
- Hemophilia
- Polyarticular Idiopathic Juvenile Arthritis
- Carnitine Deficiency
- Limbal Stem Cell Deficiency
- Peyronie’s Disease
- Transfusional Iron Overload
- Urea Cycle Disorders
- Dupuytren’s Disease
- Amyotrophic Lateral Sclerosis
- Huntington’s Disease
- Keratoconjunctivitis
- Neuropathy (Multifocal Motor)
- Hypoparathyroidism
- Nevoid Basal Cell Carcinoma Syndrome
- Barrett’s Oesophagus
- Leukaemia (Chronic Myelomonocytic) & Myelodysplastic Syndrome
- Duchenne Muscular Dystrophy (DMD)
